Medical Devices & Consumables
Global Influenza ELISA Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 594853
- Pages: 169
- Figures: 169
- Views: 1
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Influenza ELISA Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
MyBioSource
XpressBio
Abbexa
Sino Biological
Novus Biologicals
Biorbyt
DEMEDITEC Diagnostics
Eagle Bioscience
Krishgen Biosystems
United States Biological
Abnova Corporation
IBL
Aviva Systems Biology
Biomatik
Segment by Type
IgM
IgG
Segment by Application
Hospital
Laboratory
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Influenza ELISA Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Influenza ELISA Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
MyBioSource
XpressBio
Abbexa
Sino Biological
Novus Biologicals
Biorbyt
DEMEDITEC Diagnostics
Eagle Bioscience
Krishgen Biosystems
United States Biological
Abnova Corporation
IBL
Aviva Systems Biology
Biomatik
Segment by Type
IgM
IgG
Segment by Application
Hospital
Laboratory
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Influenza ELISA Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Influenza ELISA Kits: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Influenza ELISA Kits Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 IgM
1.2.3 IgG
1.3 Market Segmentation by Application
1.3.1 Global Influenza ELISA Kits Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Influenza ELISA Kits Revenue Estimates and Forecasts 2020-2031
2.2 Global Influenza ELISA Kits Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Influenza ELISA Kits Sales Estimates and Forecasts 2020-2031
2.4 Global Influenza ELISA Kits Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Influenza ELISA Kits Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Influenza ELISA Kits Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 IgM Market Size by Manufacturers
3.5.2 IgG Market Size by Manufacturers
3.6 Global Influenza ELISA Kits Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Influenza ELISA Kits Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Influenza ELISA Kits Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Influenza ELISA Kits Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Influenza ELISA Kits Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Influenza ELISA Kits Sales and Revenue by Type (2020-2031)
6.4 North America Influenza ELISA Kits Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Influenza ELISA Kits Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Influenza ELISA Kits Sales and Revenue by Type (2020-2031)
7.4 Europe Influenza ELISA Kits Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Influenza ELISA Kits Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Influenza ELISA Kits Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Influenza ELISA Kits Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Influenza ELISA Kits Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Influenza ELISA Kits Sales and Revenue by Type (2020-2031)
9.4 Central and South America Influenza ELISA Kits Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Influenza ELISA Kits Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Influenza ELISA Kits Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Influenza ELISA Kits Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Influenza ELISA Kits Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 MyBioSource
11.1.1 MyBioSource Corporation Information
11.1.2 MyBioSource Business Overview
11.1.3 MyBioSource Influenza ELISA Kits Product Models, Descriptions and Specifications
11.1.4 MyBioSource Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 MyBioSource Influenza ELISA Kits Sales by Product in 2024
11.1.6 MyBioSource Influenza ELISA Kits Sales by Application in 2024
11.1.7 MyBioSource Influenza ELISA Kits Sales by Geographic Area in 2024
11.1.8 MyBioSource Influenza ELISA Kits SWOT Analysis
11.1.9 MyBioSource Recent Developments
11.2 XpressBio
11.2.1 XpressBio Corporation Information
11.2.2 XpressBio Business Overview
11.2.3 XpressBio Influenza ELISA Kits Product Models, Descriptions and Specifications
11.2.4 XpressBio Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 XpressBio Influenza ELISA Kits Sales by Product in 2024
11.2.6 XpressBio Influenza ELISA Kits Sales by Application in 2024
11.2.7 XpressBio Influenza ELISA Kits Sales by Geographic Area in 2024
11.2.8 XpressBio Influenza ELISA Kits SWOT Analysis
11.2.9 XpressBio Recent Developments
11.3 Abbexa
11.3.1 Abbexa Corporation Information
11.3.2 Abbexa Business Overview
11.3.3 Abbexa Influenza ELISA Kits Product Models, Descriptions and Specifications
11.3.4 Abbexa Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Abbexa Influenza ELISA Kits Sales by Product in 2024
11.3.6 Abbexa Influenza ELISA Kits Sales by Application in 2024
11.3.7 Abbexa Influenza ELISA Kits Sales by Geographic Area in 2024
11.3.8 Abbexa Influenza ELISA Kits SWOT Analysis
11.3.9 Abbexa Recent Developments
11.4 Sino Biological
11.4.1 Sino Biological Corporation Information
11.4.2 Sino Biological Business Overview
11.4.3 Sino Biological Influenza ELISA Kits Product Models, Descriptions and Specifications
11.4.4 Sino Biological Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sino Biological Influenza ELISA Kits Sales by Product in 2024
11.4.6 Sino Biological Influenza ELISA Kits Sales by Application in 2024
11.4.7 Sino Biological Influenza ELISA Kits Sales by Geographic Area in 2024
11.4.8 Sino Biological Influenza ELISA Kits SWOT Analysis
11.4.9 Sino Biological Recent Developments
11.5 Novus Biologicals
11.5.1 Novus Biologicals Corporation Information
11.5.2 Novus Biologicals Business Overview
11.5.3 Novus Biologicals Influenza ELISA Kits Product Models, Descriptions and Specifications
11.5.4 Novus Biologicals Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Novus Biologicals Influenza ELISA Kits Sales by Product in 2024
11.5.6 Novus Biologicals Influenza ELISA Kits Sales by Application in 2024
11.5.7 Novus Biologicals Influenza ELISA Kits Sales by Geographic Area in 2024
11.5.8 Novus Biologicals Influenza ELISA Kits SWOT Analysis
11.5.9 Novus Biologicals Recent Developments
11.6 Biorbyt
11.6.1 Biorbyt Corporation Information
11.6.2 Biorbyt Business Overview
11.6.3 Biorbyt Influenza ELISA Kits Product Models, Descriptions and Specifications
11.6.4 Biorbyt Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Biorbyt Recent Developments
11.7 DEMEDITEC Diagnostics
11.7.1 DEMEDITEC Diagnostics Corporation Information
11.7.2 DEMEDITEC Diagnostics Business Overview
11.7.3 DEMEDITEC Diagnostics Influenza ELISA Kits Product Models, Descriptions and Specifications
11.7.4 DEMEDITEC Diagnostics Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 DEMEDITEC Diagnostics Recent Developments
11.8 Eagle Bioscience
11.8.1 Eagle Bioscience Corporation Information
11.8.2 Eagle Bioscience Business Overview
11.8.3 Eagle Bioscience Influenza ELISA Kits Product Models, Descriptions and Specifications
11.8.4 Eagle Bioscience Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Eagle Bioscience Recent Developments
11.9 Krishgen Biosystems
11.9.1 Krishgen Biosystems Corporation Information
11.9.2 Krishgen Biosystems Business Overview
11.9.3 Krishgen Biosystems Influenza ELISA Kits Product Models, Descriptions and Specifications
11.9.4 Krishgen Biosystems Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Krishgen Biosystems Recent Developments
11.10 United States Biological
11.10.1 United States Biological Corporation Information
11.10.2 United States Biological Business Overview
11.10.3 United States Biological Influenza ELISA Kits Product Models, Descriptions and Specifications
11.10.4 United States Biological Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 United States Biological Recent Developments
11.11 Abnova Corporation
11.11.1 Abnova Corporation Corporation Information
11.11.2 Abnova Corporation Business Overview
11.11.3 Abnova Corporation Influenza ELISA Kits Product Models, Descriptions and Specifications
11.11.4 Abnova Corporation Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Abnova Corporation Recent Developments
11.12 IBL
11.12.1 IBL Corporation Information
11.12.2 IBL Business Overview
11.12.3 IBL Influenza ELISA Kits Product Models, Descriptions and Specifications
11.12.4 IBL Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 IBL Recent Developments
11.13 Aviva Systems Biology
11.13.1 Aviva Systems Biology Corporation Information
11.13.2 Aviva Systems Biology Business Overview
11.13.3 Aviva Systems Biology Influenza ELISA Kits Product Models, Descriptions and Specifications
11.13.4 Aviva Systems Biology Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Aviva Systems Biology Recent Developments
11.14 Biomatik
11.14.1 Biomatik Corporation Information
11.14.2 Biomatik Business Overview
11.14.3 Biomatik Influenza ELISA Kits Product Models, Descriptions and Specifications
11.14.4 Biomatik Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Biomatik Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Influenza ELISA Kits Industry Chain
12.2 Influenza ELISA Kits Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Influenza ELISA Kits Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Influenza ELISA Kits Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Influenza ELISA Kits Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Influenza ELISA Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Influenza ELISA Kits: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Influenza ELISA Kits Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 IgM
1.2.3 IgG
1.3 Market Segmentation by Application
1.3.1 Global Influenza ELISA Kits Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Influenza ELISA Kits Revenue Estimates and Forecasts 2020-2031
2.2 Global Influenza ELISA Kits Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Influenza ELISA Kits Sales Estimates and Forecasts 2020-2031
2.4 Global Influenza ELISA Kits Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Influenza ELISA Kits Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Influenza ELISA Kits Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 IgM Market Size by Manufacturers
3.5.2 IgG Market Size by Manufacturers
3.6 Global Influenza ELISA Kits Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Influenza ELISA Kits Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Influenza ELISA Kits Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Influenza ELISA Kits Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Influenza ELISA Kits Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Influenza ELISA Kits Sales and Revenue by Type (2020-2031)
6.4 North America Influenza ELISA Kits Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Influenza ELISA Kits Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Influenza ELISA Kits Sales and Revenue by Type (2020-2031)
7.4 Europe Influenza ELISA Kits Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Influenza ELISA Kits Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Influenza ELISA Kits Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Influenza ELISA Kits Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Influenza ELISA Kits Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Influenza ELISA Kits Sales and Revenue by Type (2020-2031)
9.4 Central and South America Influenza ELISA Kits Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Influenza ELISA Kits Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Influenza ELISA Kits Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Influenza ELISA Kits Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Influenza ELISA Kits Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 MyBioSource
11.1.1 MyBioSource Corporation Information
11.1.2 MyBioSource Business Overview
11.1.3 MyBioSource Influenza ELISA Kits Product Models, Descriptions and Specifications
11.1.4 MyBioSource Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 MyBioSource Influenza ELISA Kits Sales by Product in 2024
11.1.6 MyBioSource Influenza ELISA Kits Sales by Application in 2024
11.1.7 MyBioSource Influenza ELISA Kits Sales by Geographic Area in 2024
11.1.8 MyBioSource Influenza ELISA Kits SWOT Analysis
11.1.9 MyBioSource Recent Developments
11.2 XpressBio
11.2.1 XpressBio Corporation Information
11.2.2 XpressBio Business Overview
11.2.3 XpressBio Influenza ELISA Kits Product Models, Descriptions and Specifications
11.2.4 XpressBio Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 XpressBio Influenza ELISA Kits Sales by Product in 2024
11.2.6 XpressBio Influenza ELISA Kits Sales by Application in 2024
11.2.7 XpressBio Influenza ELISA Kits Sales by Geographic Area in 2024
11.2.8 XpressBio Influenza ELISA Kits SWOT Analysis
11.2.9 XpressBio Recent Developments
11.3 Abbexa
11.3.1 Abbexa Corporation Information
11.3.2 Abbexa Business Overview
11.3.3 Abbexa Influenza ELISA Kits Product Models, Descriptions and Specifications
11.3.4 Abbexa Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Abbexa Influenza ELISA Kits Sales by Product in 2024
11.3.6 Abbexa Influenza ELISA Kits Sales by Application in 2024
11.3.7 Abbexa Influenza ELISA Kits Sales by Geographic Area in 2024
11.3.8 Abbexa Influenza ELISA Kits SWOT Analysis
11.3.9 Abbexa Recent Developments
11.4 Sino Biological
11.4.1 Sino Biological Corporation Information
11.4.2 Sino Biological Business Overview
11.4.3 Sino Biological Influenza ELISA Kits Product Models, Descriptions and Specifications
11.4.4 Sino Biological Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sino Biological Influenza ELISA Kits Sales by Product in 2024
11.4.6 Sino Biological Influenza ELISA Kits Sales by Application in 2024
11.4.7 Sino Biological Influenza ELISA Kits Sales by Geographic Area in 2024
11.4.8 Sino Biological Influenza ELISA Kits SWOT Analysis
11.4.9 Sino Biological Recent Developments
11.5 Novus Biologicals
11.5.1 Novus Biologicals Corporation Information
11.5.2 Novus Biologicals Business Overview
11.5.3 Novus Biologicals Influenza ELISA Kits Product Models, Descriptions and Specifications
11.5.4 Novus Biologicals Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Novus Biologicals Influenza ELISA Kits Sales by Product in 2024
11.5.6 Novus Biologicals Influenza ELISA Kits Sales by Application in 2024
11.5.7 Novus Biologicals Influenza ELISA Kits Sales by Geographic Area in 2024
11.5.8 Novus Biologicals Influenza ELISA Kits SWOT Analysis
11.5.9 Novus Biologicals Recent Developments
11.6 Biorbyt
11.6.1 Biorbyt Corporation Information
11.6.2 Biorbyt Business Overview
11.6.3 Biorbyt Influenza ELISA Kits Product Models, Descriptions and Specifications
11.6.4 Biorbyt Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Biorbyt Recent Developments
11.7 DEMEDITEC Diagnostics
11.7.1 DEMEDITEC Diagnostics Corporation Information
11.7.2 DEMEDITEC Diagnostics Business Overview
11.7.3 DEMEDITEC Diagnostics Influenza ELISA Kits Product Models, Descriptions and Specifications
11.7.4 DEMEDITEC Diagnostics Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 DEMEDITEC Diagnostics Recent Developments
11.8 Eagle Bioscience
11.8.1 Eagle Bioscience Corporation Information
11.8.2 Eagle Bioscience Business Overview
11.8.3 Eagle Bioscience Influenza ELISA Kits Product Models, Descriptions and Specifications
11.8.4 Eagle Bioscience Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Eagle Bioscience Recent Developments
11.9 Krishgen Biosystems
11.9.1 Krishgen Biosystems Corporation Information
11.9.2 Krishgen Biosystems Business Overview
11.9.3 Krishgen Biosystems Influenza ELISA Kits Product Models, Descriptions and Specifications
11.9.4 Krishgen Biosystems Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Krishgen Biosystems Recent Developments
11.10 United States Biological
11.10.1 United States Biological Corporation Information
11.10.2 United States Biological Business Overview
11.10.3 United States Biological Influenza ELISA Kits Product Models, Descriptions and Specifications
11.10.4 United States Biological Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 United States Biological Recent Developments
11.11 Abnova Corporation
11.11.1 Abnova Corporation Corporation Information
11.11.2 Abnova Corporation Business Overview
11.11.3 Abnova Corporation Influenza ELISA Kits Product Models, Descriptions and Specifications
11.11.4 Abnova Corporation Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Abnova Corporation Recent Developments
11.12 IBL
11.12.1 IBL Corporation Information
11.12.2 IBL Business Overview
11.12.3 IBL Influenza ELISA Kits Product Models, Descriptions and Specifications
11.12.4 IBL Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 IBL Recent Developments
11.13 Aviva Systems Biology
11.13.1 Aviva Systems Biology Corporation Information
11.13.2 Aviva Systems Biology Business Overview
11.13.3 Aviva Systems Biology Influenza ELISA Kits Product Models, Descriptions and Specifications
11.13.4 Aviva Systems Biology Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Aviva Systems Biology Recent Developments
11.14 Biomatik
11.14.1 Biomatik Corporation Information
11.14.2 Biomatik Business Overview
11.14.3 Biomatik Influenza ELISA Kits Product Models, Descriptions and Specifications
11.14.4 Biomatik Influenza ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Biomatik Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Influenza ELISA Kits Industry Chain
12.2 Influenza ELISA Kits Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Influenza ELISA Kits Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Influenza ELISA Kits Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Influenza ELISA Kits Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Influenza ELISA Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Influenza ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Influenza ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Influenza ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Influenza ELISA Kits Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Influenza ELISA Kits Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Influenza ELISA Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Influenza ELISA Kits Sales by Region (2020-2025) & (K Units)
Table 8. Global Influenza ELISA Kits Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Influenza ELISA Kits Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Influenza ELISA Kits Sales Share by Manufacturers (2020-2025)
Table 12. Global Influenza ELISA Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Influenza ELISA Kits Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Influenza ELISA Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza ELISA Kits as of 2024)
Table 16. Global Influenza ELISA Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Influenza ELISA Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Influenza ELISA Kits Manufacturing Base and Headquarters
Table 19. Global Influenza ELISA Kits Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Influenza ELISA Kits Sales by Type (2020-2025) & (K Units)
Table 23. Global Influenza ELISA Kits Sales by Type (2026-2031) & (K Units)
Table 24. Global Influenza ELISA Kits Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Influenza ELISA Kits Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Influenza ELISA Kits ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Influenza ELISA Kits Sales by Application (2020-2025) & (K Units)
Table 29. Global Influenza ELISA Kits Sales by Application (2026-2031) & (K Units)
Table 30. Influenza ELISA Kits High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Influenza ELISA Kits Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Influenza ELISA Kits Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Influenza ELISA Kits ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Influenza ELISA Kits Growth Accelerators and Market Barriers
Table 37. North America Influenza ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Influenza ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Influenza ELISA Kits Growth Accelerators and Market Barriers
Table 40. Europe Influenza ELISA Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Influenza ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Influenza ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Influenza ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Influenza ELISA Kits Growth Accelerators and Market Barriers
Table 45. Southeast Asia Influenza ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Influenza ELISA Kits Investment Opportunities and Key Challenges
Table 47. Central and South America Influenza ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Influenza ELISA Kits Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Influenza ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. MyBioSource Corporation Information
Table 51. MyBioSource Description and Major Businesses
Table 52. MyBioSource Product Models, Descriptions and Specifications
Table 53. MyBioSource Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. MyBioSource Sales Value Proportion by Product in 2024
Table 55. MyBioSource Sales Value Proportion by Application in 2024
Table 56. MyBioSource Sales Value Proportion by Geographic Area in 2024
Table 57. MyBioSource Influenza ELISA Kits SWOT Analysis
Table 58. MyBioSource Recent Developments
Table 59. XpressBio Corporation Information
Table 60. XpressBio Description and Major Businesses
Table 61. XpressBio Product Models, Descriptions and Specifications
Table 62. XpressBio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. XpressBio Sales Value Proportion by Product in 2024
Table 64. XpressBio Sales Value Proportion by Application in 2024
Table 65. XpressBio Sales Value Proportion by Geographic Area in 2024
Table 66. XpressBio Influenza ELISA Kits SWOT Analysis
Table 67. XpressBio Recent Developments
Table 68. Abbexa Corporation Information
Table 69. Abbexa Description and Major Businesses
Table 70. Abbexa Product Models, Descriptions and Specifications
Table 71. Abbexa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Abbexa Sales Value Proportion by Product in 2024
Table 73. Abbexa Sales Value Proportion by Application in 2024
Table 74. Abbexa Sales Value Proportion by Geographic Area in 2024
Table 75. Abbexa Influenza ELISA Kits SWOT Analysis
Table 76. Abbexa Recent Developments
Table 77. Sino Biological Corporation Information
Table 78. Sino Biological Description and Major Businesses
Table 79. Sino Biological Product Models, Descriptions and Specifications
Table 80. Sino Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Sino Biological Sales Value Proportion by Product in 2024
Table 82. Sino Biological Sales Value Proportion by Application in 2024
Table 83. Sino Biological Sales Value Proportion by Geographic Area in 2024
Table 84. Sino Biological Influenza ELISA Kits SWOT Analysis
Table 85. Sino Biological Recent Developments
Table 86. Novus Biologicals Corporation Information
Table 87. Novus Biologicals Description and Major Businesses
Table 88. Novus Biologicals Product Models, Descriptions and Specifications
Table 89. Novus Biologicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Novus Biologicals Sales Value Proportion by Product in 2024
Table 91. Novus Biologicals Sales Value Proportion by Application in 2024
Table 92. Novus Biologicals Sales Value Proportion by Geographic Area in 2024
Table 93. Novus Biologicals Influenza ELISA Kits SWOT Analysis
Table 94. Novus Biologicals Recent Developments
Table 95. Biorbyt Corporation Information
Table 96. Biorbyt Description and Major Businesses
Table 97. Biorbyt Product Models, Descriptions and Specifications
Table 98. Biorbyt Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Biorbyt Recent Developments
Table 100. DEMEDITEC Diagnostics Corporation Information
Table 101. DEMEDITEC Diagnostics Description and Major Businesses
Table 102. DEMEDITEC Diagnostics Product Models, Descriptions and Specifications
Table 103. DEMEDITEC Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. DEMEDITEC Diagnostics Recent Developments
Table 105. Eagle Bioscience Corporation Information
Table 106. Eagle Bioscience Description and Major Businesses
Table 107. Eagle Bioscience Product Models, Descriptions and Specifications
Table 108. Eagle Bioscience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Eagle Bioscience Recent Developments
Table 110. Krishgen Biosystems Corporation Information
Table 111. Krishgen Biosystems Description and Major Businesses
Table 112. Krishgen Biosystems Product Models, Descriptions and Specifications
Table 113. Krishgen Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Krishgen Biosystems Recent Developments
Table 115. United States Biological Corporation Information
Table 116. United States Biological Description and Major Businesses
Table 117. United States Biological Product Models, Descriptions and Specifications
Table 118. United States Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. United States Biological Recent Developments
Table 120. Abnova Corporation Corporation Information
Table 121. Abnova Corporation Description and Major Businesses
Table 122. Abnova Corporation Product Models, Descriptions and Specifications
Table 123. Abnova Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Abnova Corporation Recent Developments
Table 125. IBL Corporation Information
Table 126. IBL Description and Major Businesses
Table 127. IBL Product Models, Descriptions and Specifications
Table 128. IBL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. IBL Recent Developments
Table 130. Aviva Systems Biology Corporation Information
Table 131. Aviva Systems Biology Description and Major Businesses
Table 132. Aviva Systems Biology Product Models, Descriptions and Specifications
Table 133. Aviva Systems Biology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Aviva Systems Biology Recent Developments
Table 135. Biomatik Corporation Information
Table 136. Biomatik Description and Major Businesses
Table 137. Biomatik Product Models, Descriptions and Specifications
Table 138. Biomatik Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Biomatik Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza ELISA Kits Product Picture
Figure 2. Global Influenza ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. IgM Product Picture
Figure 4. IgG Product Picture
Figure 5. Global Influenza ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Laboratory
Figure 8. Others
Figure 9. Influenza ELISA Kits Report Years Considered
Figure 10. Global Influenza ELISA Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 12. Global Influenza ELISA Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Influenza ELISA Kits Revenue Market Share by Region (2020-2031)
Figure 14. Global Influenza ELISA Kits Sales (2020-2031) & (K Units)
Figure 15. Global Influenza ELISA Kits Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Influenza ELISA Kits Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Influenza ELISA Kits Sales Volume Market Share in 2024
Figure 18. Global Influenza ELISA Kits Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. IgM Revenue Market Share by Manufacturer in 2024
Figure 21. IgG Revenue Market Share by Manufacturer in 2024
Figure 22. Global Influenza ELISA Kits Sales Market Share by Type (2020-2031)
Figure 23. Global Influenza ELISA Kits Revenue Market Share by Type (2020-2031)
Figure 24. Global Influenza ELISA Kits Sales Market Share by Application (2020-2031)
Figure 25. Global Influenza ELISA Kits Revenue Market Share by Application (2020-2031)
Figure 26. North America Influenza ELISA Kits Sales YoY (2020-2031) & (K Units)
Figure 27. North America Influenza ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Influenza ELISA Kits Sales Revenue (US$ Million) in 2024
Figure 29. North America Influenza ELISA Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Influenza ELISA Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Influenza ELISA Kits Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Influenza ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Influenza ELISA Kits Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Influenza ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Influenza ELISA Kits Sales Revenue (US$ Million) in 2024
Figure 39. Europe Influenza ELISA Kits Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Influenza ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Influenza ELISA Kits Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Influenza ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 44. France Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Influenza ELISA Kits Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Influenza ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Influenza ELISA Kits Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Influenza ELISA Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Influenza ELISA Kits Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Influenza ELISA Kits Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Influenza ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 59. India Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Influenza ELISA Kits Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Influenza ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Influenza ELISA Kits Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Influenza ELISA Kits Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Influenza ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Influenza ELISA Kits Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Influenza ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Influenza ELISA Kits Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Influenza ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Influenza ELISA Kits Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Influenza ELISA Kits Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Influenza ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Influenza ELISA Kits Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Influenza ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 80. Influenza ELISA Kits Industry Chain Mapping
Figure 81. Regional Influenza ELISA Kits Manufacturing Base Distribution (%)
Figure 82. Global Influenza ELISA Kits Production Market Share by Region (2020-2031)
Figure 83. Influenza ELISA Kits Production Process
Figure 84. Regional Influenza ELISA Kits Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Table 1. Global Influenza ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Influenza ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Influenza ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Influenza ELISA Kits Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Influenza ELISA Kits Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Influenza ELISA Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Influenza ELISA Kits Sales by Region (2020-2025) & (K Units)
Table 8. Global Influenza ELISA Kits Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Influenza ELISA Kits Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Influenza ELISA Kits Sales Share by Manufacturers (2020-2025)
Table 12. Global Influenza ELISA Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Influenza ELISA Kits Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Influenza ELISA Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza ELISA Kits as of 2024)
Table 16. Global Influenza ELISA Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Influenza ELISA Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Influenza ELISA Kits Manufacturing Base and Headquarters
Table 19. Global Influenza ELISA Kits Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Influenza ELISA Kits Sales by Type (2020-2025) & (K Units)
Table 23. Global Influenza ELISA Kits Sales by Type (2026-2031) & (K Units)
Table 24. Global Influenza ELISA Kits Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Influenza ELISA Kits Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Influenza ELISA Kits ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Influenza ELISA Kits Sales by Application (2020-2025) & (K Units)
Table 29. Global Influenza ELISA Kits Sales by Application (2026-2031) & (K Units)
Table 30. Influenza ELISA Kits High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Influenza ELISA Kits Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Influenza ELISA Kits Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Influenza ELISA Kits ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Influenza ELISA Kits Growth Accelerators and Market Barriers
Table 37. North America Influenza ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Influenza ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Influenza ELISA Kits Growth Accelerators and Market Barriers
Table 40. Europe Influenza ELISA Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Influenza ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Influenza ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Influenza ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Influenza ELISA Kits Growth Accelerators and Market Barriers
Table 45. Southeast Asia Influenza ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Influenza ELISA Kits Investment Opportunities and Key Challenges
Table 47. Central and South America Influenza ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Influenza ELISA Kits Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Influenza ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. MyBioSource Corporation Information
Table 51. MyBioSource Description and Major Businesses
Table 52. MyBioSource Product Models, Descriptions and Specifications
Table 53. MyBioSource Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. MyBioSource Sales Value Proportion by Product in 2024
Table 55. MyBioSource Sales Value Proportion by Application in 2024
Table 56. MyBioSource Sales Value Proportion by Geographic Area in 2024
Table 57. MyBioSource Influenza ELISA Kits SWOT Analysis
Table 58. MyBioSource Recent Developments
Table 59. XpressBio Corporation Information
Table 60. XpressBio Description and Major Businesses
Table 61. XpressBio Product Models, Descriptions and Specifications
Table 62. XpressBio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. XpressBio Sales Value Proportion by Product in 2024
Table 64. XpressBio Sales Value Proportion by Application in 2024
Table 65. XpressBio Sales Value Proportion by Geographic Area in 2024
Table 66. XpressBio Influenza ELISA Kits SWOT Analysis
Table 67. XpressBio Recent Developments
Table 68. Abbexa Corporation Information
Table 69. Abbexa Description and Major Businesses
Table 70. Abbexa Product Models, Descriptions and Specifications
Table 71. Abbexa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Abbexa Sales Value Proportion by Product in 2024
Table 73. Abbexa Sales Value Proportion by Application in 2024
Table 74. Abbexa Sales Value Proportion by Geographic Area in 2024
Table 75. Abbexa Influenza ELISA Kits SWOT Analysis
Table 76. Abbexa Recent Developments
Table 77. Sino Biological Corporation Information
Table 78. Sino Biological Description and Major Businesses
Table 79. Sino Biological Product Models, Descriptions and Specifications
Table 80. Sino Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Sino Biological Sales Value Proportion by Product in 2024
Table 82. Sino Biological Sales Value Proportion by Application in 2024
Table 83. Sino Biological Sales Value Proportion by Geographic Area in 2024
Table 84. Sino Biological Influenza ELISA Kits SWOT Analysis
Table 85. Sino Biological Recent Developments
Table 86. Novus Biologicals Corporation Information
Table 87. Novus Biologicals Description and Major Businesses
Table 88. Novus Biologicals Product Models, Descriptions and Specifications
Table 89. Novus Biologicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Novus Biologicals Sales Value Proportion by Product in 2024
Table 91. Novus Biologicals Sales Value Proportion by Application in 2024
Table 92. Novus Biologicals Sales Value Proportion by Geographic Area in 2024
Table 93. Novus Biologicals Influenza ELISA Kits SWOT Analysis
Table 94. Novus Biologicals Recent Developments
Table 95. Biorbyt Corporation Information
Table 96. Biorbyt Description and Major Businesses
Table 97. Biorbyt Product Models, Descriptions and Specifications
Table 98. Biorbyt Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Biorbyt Recent Developments
Table 100. DEMEDITEC Diagnostics Corporation Information
Table 101. DEMEDITEC Diagnostics Description and Major Businesses
Table 102. DEMEDITEC Diagnostics Product Models, Descriptions and Specifications
Table 103. DEMEDITEC Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. DEMEDITEC Diagnostics Recent Developments
Table 105. Eagle Bioscience Corporation Information
Table 106. Eagle Bioscience Description and Major Businesses
Table 107. Eagle Bioscience Product Models, Descriptions and Specifications
Table 108. Eagle Bioscience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Eagle Bioscience Recent Developments
Table 110. Krishgen Biosystems Corporation Information
Table 111. Krishgen Biosystems Description and Major Businesses
Table 112. Krishgen Biosystems Product Models, Descriptions and Specifications
Table 113. Krishgen Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Krishgen Biosystems Recent Developments
Table 115. United States Biological Corporation Information
Table 116. United States Biological Description and Major Businesses
Table 117. United States Biological Product Models, Descriptions and Specifications
Table 118. United States Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. United States Biological Recent Developments
Table 120. Abnova Corporation Corporation Information
Table 121. Abnova Corporation Description and Major Businesses
Table 122. Abnova Corporation Product Models, Descriptions and Specifications
Table 123. Abnova Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Abnova Corporation Recent Developments
Table 125. IBL Corporation Information
Table 126. IBL Description and Major Businesses
Table 127. IBL Product Models, Descriptions and Specifications
Table 128. IBL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. IBL Recent Developments
Table 130. Aviva Systems Biology Corporation Information
Table 131. Aviva Systems Biology Description and Major Businesses
Table 132. Aviva Systems Biology Product Models, Descriptions and Specifications
Table 133. Aviva Systems Biology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Aviva Systems Biology Recent Developments
Table 135. Biomatik Corporation Information
Table 136. Biomatik Description and Major Businesses
Table 137. Biomatik Product Models, Descriptions and Specifications
Table 138. Biomatik Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Biomatik Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza ELISA Kits Product Picture
Figure 2. Global Influenza ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. IgM Product Picture
Figure 4. IgG Product Picture
Figure 5. Global Influenza ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Laboratory
Figure 8. Others
Figure 9. Influenza ELISA Kits Report Years Considered
Figure 10. Global Influenza ELISA Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 12. Global Influenza ELISA Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Influenza ELISA Kits Revenue Market Share by Region (2020-2031)
Figure 14. Global Influenza ELISA Kits Sales (2020-2031) & (K Units)
Figure 15. Global Influenza ELISA Kits Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Influenza ELISA Kits Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Influenza ELISA Kits Sales Volume Market Share in 2024
Figure 18. Global Influenza ELISA Kits Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. IgM Revenue Market Share by Manufacturer in 2024
Figure 21. IgG Revenue Market Share by Manufacturer in 2024
Figure 22. Global Influenza ELISA Kits Sales Market Share by Type (2020-2031)
Figure 23. Global Influenza ELISA Kits Revenue Market Share by Type (2020-2031)
Figure 24. Global Influenza ELISA Kits Sales Market Share by Application (2020-2031)
Figure 25. Global Influenza ELISA Kits Revenue Market Share by Application (2020-2031)
Figure 26. North America Influenza ELISA Kits Sales YoY (2020-2031) & (K Units)
Figure 27. North America Influenza ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Influenza ELISA Kits Sales Revenue (US$ Million) in 2024
Figure 29. North America Influenza ELISA Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Influenza ELISA Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Influenza ELISA Kits Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Influenza ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Influenza ELISA Kits Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Influenza ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Influenza ELISA Kits Sales Revenue (US$ Million) in 2024
Figure 39. Europe Influenza ELISA Kits Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Influenza ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Influenza ELISA Kits Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Influenza ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 44. France Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Influenza ELISA Kits Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Influenza ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Influenza ELISA Kits Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Influenza ELISA Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Influenza ELISA Kits Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Influenza ELISA Kits Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Influenza ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 59. India Influenza ELISA Kits Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Influenza ELISA Kits Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Influenza ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Influenza ELISA Kits Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Influenza ELISA Kits Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Influenza ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Influenza ELISA Kits Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Influenza ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Influenza ELISA Kits Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Influenza ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Influenza ELISA Kits Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Influenza ELISA Kits Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Influenza ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Influenza ELISA Kits Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Influenza ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Influenza ELISA Kits Revenue (2020-2025) & (US$ Million)
Figure 80. Influenza ELISA Kits Industry Chain Mapping
Figure 81. Regional Influenza ELISA Kits Manufacturing Base Distribution (%)
Figure 82. Global Influenza ELISA Kits Production Market Share by Region (2020-2031)
Figure 83. Influenza ELISA Kits Production Process
Figure 84. Regional Influenza ELISA Kits Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232